Trastuzumab BS IV infusion 60mg “CTH” is a biosimilar of trastuzumab (genetical recombination), manufactured by Celltrion. This injectable drug (YJ code: 4291442D1025) is supplied as 60mg per bottle and is used to treat certain types of breast cancer and metastatic gastric cancer.
Trastuzumab BS IV infusion 60mg “CTH”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →